ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancer

Mohamed I Saad1,2, Sultan Alhayyani1,2, Louise McLeod1,2

  • 1Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Vic., Australia.

Insights

Targeting ADAM17 protease is a promising strategy for KRAS-mutant lung adenocarcinoma. Blocking ADAM17 reduces tumor growth by inhibiting proliferation and IL-6 trans-signaling pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Oncogenic KRAS mutations are key drivers of lung adenocarcinoma (LAC).
  • Directly targeting KRAS has proven challenging, necessitating alternative therapeutic strategies.
  • ADAM17 protease has emerged as a potential mediator in KRAS-driven cancers.

Purpose of the Study:

  • To investigate the role of ADAM17 protease in KRAS-driven lung adenocarcinoma.
  • To determine if ADAM17 is a druggable target for treating KRAS-mutant LAC.
  • To elucidate the molecular mechanisms by which ADAM17 promotes tumor growth.

Main Methods:

  • Utilized genetically engineered and xenograft models of KRAS G12D-driven LAC.
  • Employed a non-toxic prodomain inhibitor to block ADAM17 activity.
  • Assessed tumor burden, cellular proliferation, and MAPK signaling pathways (p38, ERK).
  • Investigated the role of ADAM17 substrate IL-6R and IL-6 trans-signaling.
  • Analyzed phospho-ADAM17 levels in human KRAS-mutant LAC samples.

Main Results:

  • Specific blockade of ADAM17 significantly suppressed tumor burden and reduced cellular proliferation in KRAS G12D-driven LAC models.
  • ADAM17's pro-tumorigenic activity was dependent on p38 MAPK-mediated threonine phosphorylation.
  • ADAM17 shedding of IL-6R released soluble IL-6R, driving IL-6 trans-signaling via ERK1/2 MAPK.
  • The requirement for ADAM17 was independent of bone marrow-derived immune cells.
  • Human KRAS-mutant LAC showed a positive correlation between phospho-ADAM17 levels and activated ERK/p38 MAPK pathways.

Conclusions:

  • ADAM17 is an obligate requirement for oncogenic KRAS-driven lung adenocarcinoma.
  • ADAM17 is a druggable target for therapeutic intervention in KRAS-mutant LAC.
  • Targeting ADAM17 offers a promising strategy for treating KRAS-driven cancers.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.2K
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
65.9K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
16.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
Perpendicular-Axis Theorem01:16

Perpendicular-Axis Theorem

The perpendicular-axis theorem states that the moment of inertia of a planar object about an axis perpendicular to its plane is equal to the sum of the moments of inertia about two mutually perpendicular concurrent axes lying in the plane of the body.
Consider a circular disc of mass M and radius R lying along an x-y plane. The origin lies at the center of the disc, and the z-axis is perpendicular to the disc's plane. All three axes coincide at the disc's center. The moment of inertia of this...
4.5K
Parallel-axis Theorem01:06

Parallel-axis Theorem

The parallel-axis theorem provides a convenient and quick method of finding the moment of inertia of an object about an axis parallel to the axis passing through its center of mass. Consider a thin rod as an example. There is a striking similarity between the process of finding the moment of inertia of a thin rod about an axis through its middle, where the center of mass lies, and about an axis through its end using the conventional method. In the conventional method, the concept of linear mass...
8.3K